#term ID	term description	observed gene count	background gene count	strength	signal	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
WP4655	Cytosolic DNA-sensing pathway	7	73	1.28	1.03	0.00012	9606.ENSP00000286186,9606.ENSP00000351273,9606.ENSP00000369213,9606.ENSP00000385675,9606.ENSP00000385725,9606.ENSP00000433138,9606.ENSP00000483825	CASP10,CASP8,DDX58,IL6,POLR2F,CASP1,IKBKG
WP254	Apoptosis	7	83	1.22	1.0	0.00014	9606.ENSP00000216341,9606.ENSP00000275015,9606.ENSP00000286186,9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000433138,9606.ENSP00000483825	GZMB,NFKBIE,CASP10,BID,CASP8,CASP1,IKBKG
WP231	TNF-alpha signaling pathway	7	92	1.18	0.96	0.00018	9606.ENSP00000275015,9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000351908,9606.ENSP00000385675,9606.ENSP00000394560,9606.ENSP00000483825	NFKBIE,BID,CASP8,MAP3K5,IL6,MAPK9,IKBKG
WP4666	Hepatitis B infection	8	150	1.02	0.87	0.00027	9606.ENSP00000286186,9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000369213,9606.ENSP00000385675,9606.ENSP00000389377,9606.ENSP00000394560,9606.ENSP00000483825	CASP10,BID,CASP8,DDX58,IL6,NFATC1,MAPK9,IKBKG
WP4754	IL-18 signaling pathway	10	271	0.86	0.8	0.00027	9606.ENSP00000248553,9606.ENSP00000275015,9606.ENSP00000296026,9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000355759,9606.ENSP00000356505,9606.ENSP00000361818,9606.ENSP00000385675,9606.ENSP00000394560	HSPB1,NFKBIE,CXCL3,BID,CASP8,PARP1,NCF2,SDC4,IL6,MAPK9
WP3644	NAD+ metabolism	4	16	1.69	0.99	0.00036	9606.ENSP00000222553,9606.ENSP00000355759,9606.ENSP00000366410,9606.ENSP00000367890	NAMPT,PARP1,NMNAT1,NADK
WP4136	Fibrin complement receptor 3 signaling pathway	5	43	1.36	0.91	0.00048	9606.ENSP00000296026,9606.ENSP00000380948,9606.ENSP00000385675,9606.ENSP00000483825,9606.ENSP00000496959	CXCL3,ITGB2,IL6,IKBKG,ITGAM
WP3878	ATM signaling in development and disease 	5	45	1.34	0.9	0.00051	9606.ENSP00000248553,9606.ENSP00000265433,9606.ENSP00000339883,9606.ENSP00000351908,9606.ENSP00000483825	HSPB1,NBN,LBR,MAP3K5,IKBKG
WP4298	Acute viral myocarditis	6	85	1.14	0.84	0.00058	9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000355759,9606.ENSP00000380948,9606.ENSP00000385675,9606.ENSP00000433138	BID,CASP8,PARP1,ITGB2,IL6,CASP1
WP3865	Novel intracellular components of RIG-I-like receptor pathway	5	59	1.22	0.77	0.0014	9606.ENSP00000286186,9606.ENSP00000351273,9606.ENSP00000369213,9606.ENSP00000394560,9606.ENSP00000483825	CASP10,CASP8,DDX58,MAPK9,IKBKG
WP5090	Complement system in neuronal development and plasticity	6	105	1.05	0.73	0.0014	9606.ENSP00000286186,9606.ENSP00000296280,9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000380948,9606.ENSP00000496959	CASP10,MASP1,BID,CASP8,ITGB2,ITGAM
WP5115	Network map of SARS-CoV-2 signaling pathway	8	218	0.86	0.67	0.0014	9606.ENSP00000296026,9606.ENSP00000302935,9606.ENSP00000318822,9606.ENSP00000338171,9606.ENSP00000351273,9606.ENSP00000369213,9606.ENSP00000385675,9606.ENSP00000483825	CXCL3,IL16,BID,SKAP1,CASP8,DDX58,IL6,IKBKG
WP3630	NAD metabolism, sirtuins and aging	3	11	1.73	0.75	0.0026	9606.ENSP00000222553,9606.ENSP00000355759,9606.ENSP00000368880	NAMPT,PARP1,FOXO1
WP5218	Extrafollicular and follicular B cell activation by SARS-CoV-2	5	72	1.14	0.69	0.0026	9606.ENSP00000303507,9606.ENSP00000360181,9606.ENSP00000368880,9606.ENSP00000380948,9606.ENSP00000385675	BCR,SH2D1A,FOXO1,ITGB2,IL6
WP5095	Overview of proinflammatory and profibrotic mediators	6	126	0.97	0.64	0.0029	9606.ENSP00000225474,9606.ENSP00000244241,9606.ENSP00000296026,9606.ENSP00000296545,9606.ENSP00000367832,9606.ENSP00000385675	CSF3,IL17C,CXCL3,IL15,CCL7,IL6
WP2516	ATM signaling pathway	4	40	1.29	0.68	0.0035	9606.ENSP00000265433,9606.ENSP00000318822,9606.ENSP00000394560,9606.ENSP00000483825	NBN,BID,MAPK9,IKBKG
WP314	Fas ligand pathway and stress induction of heat shock proteins	4	43	1.26	0.67	0.0035	9606.ENSP00000248553,9606.ENSP00000286186,9606.ENSP00000351273,9606.ENSP00000355759	HSPB1,CASP10,CASP8,PARP1
WP3888	VEGFA-VEGFR2 signaling	10	428	0.66	0.54	0.0035	9606.ENSP00000248553,9606.ENSP00000267257,9606.ENSP00000318176,9606.ENSP00000338934,9606.ENSP00000351908,9606.ENSP00000356505,9606.ENSP00000368880,9606.ENSP00000389377,9606.ENSP00000394560,9606.ENSP00000395574	HSPB1,PXN,PRKRA,EZR,MAP3K5,NCF2,FOXO1,NFATC1,MAPK9,ELOA
WP4016	DNA IR-damage and cellular response via ATR	5	81	1.08	0.65	0.0035	9606.ENSP00000265433,9606.ENSP00000278935,9606.ENSP00000305480,9606.ENSP00000355759,9606.ENSP00000483825	NBN,CEP164,FEN1,PARP1,IKBKG
WP4630	Measles virus infection	6	135	0.94	0.62	0.0035	9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000369213,9606.ENSP00000385675,9606.ENSP00000394560,9606.ENSP00000483825	BID,CASP8,DDX58,IL6,MAPK9,IKBKG
WP5087	Malignant pleural mesothelioma	10	434	0.66	0.53	0.0035	9606.ENSP00000225474,9606.ENSP00000351908,9606.ENSP00000368710,9606.ENSP00000368880,9606.ENSP00000380948,9606.ENSP00000385334,9606.ENSP00000385675,9606.ENSP00000386896,9606.ENSP00000394560,9606.ENSP00000433138	CSF3,MAP3K5,RASSF2,FOXO1,ITGB2,MAD1L1,IL6,ITGA6,MAPK9,CASP1
WP1772	Apoptosis modulation and signaling	5	89	1.04	0.62	0.0041	9606.ENSP00000286186,9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000351908,9606.ENSP00000433138	CASP10,BID,CASP8,MAP3K5,CASP1
WP69	T-cell receptor signaling pathway	5	90	1.04	0.62	0.0041	9606.ENSP00000338171,9606.ENSP00000385675,9606.ENSP00000389377,9606.ENSP00000394560,9606.ENSP00000483825	SKAP1,IL6,NFATC1,MAPK9,IKBKG
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	8	301	0.72	0.52	0.0056	9606.ENSP00000225474,9606.ENSP00000302150,9606.ENSP00000327290,9606.ENSP00000356047,9606.ENSP00000368880,9606.ENSP00000380948,9606.ENSP00000386896,9606.ENSP00000483825	CSF3,PRL,ITGA11,PFKFB2,FOXO1,ITGB2,ITGA6,IKBKG
WP185	Integrin-mediated cell adhesion	5	99	1.0	0.58	0.0057	9606.ENSP00000267257,9606.ENSP00000327290,9606.ENSP00000380948,9606.ENSP00000386896,9606.ENSP00000496959	PXN,ITGA11,ITGB2,ITGA6,ITGAM
WP4482	Vitamin D in inflammatory diseases	3	21	1.45	0.61	0.0070	9606.ENSP00000385675,9606.ENSP00000389377,9606.ENSP00000483825	IL6,NFATC1,IKBKG
WP3645	NAD+ biosynthetic pathways	3	22	1.43	0.6	0.0077	9606.ENSP00000222553,9606.ENSP00000355759,9606.ENSP00000366410	NAMPT,PARP1,NMNAT1
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3	22	1.43	0.6	0.0077	9606.ENSP00000222553,9606.ENSP00000355759,9606.ENSP00000385675	NAMPT,PARP1,IL6
WP3945	TYROBP causal network in microglia	4	59	1.13	0.57	0.0078	9606.ENSP00000356505,9606.ENSP00000365411,9606.ENSP00000380948,9606.ENSP00000496959	NCF2,APBB1IP,ITGB2,ITGAM
WP530	Cytokines and inflammatory response	3	26	1.36	0.56	0.0108	9606.ENSP00000225474,9606.ENSP00000296545,9606.ENSP00000385675	CSF3,IL15,IL6
WP2324	AGE/RAGE pathway	4	66	1.08	0.53	0.0110	9606.ENSP00000338934,9606.ENSP00000351273,9606.ENSP00000368880,9606.ENSP00000394560	EZR,CASP8,FOXO1,MAPK9
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	4	66	1.08	0.53	0.0110	9606.ENSP00000296026,9606.ENSP00000351273,9606.ENSP00000369213,9606.ENSP00000385675	CXCL3,CASP8,DDX58,IL6
WP3303	RAC1/PAK1/p38/MMP2 pathway	4	68	1.06	0.52	0.0115	9606.ENSP00000267257,9606.ENSP00000368880,9606.ENSP00000394560,9606.ENSP00000483825	PXN,FOXO1,MAPK9,IKBKG
WP4752	Base excision repair	3	31	1.28	0.51	0.0153	9606.ENSP00000216714,9606.ENSP00000305480,9606.ENSP00000355759	APEX1,FEN1,PARP1
WP2447	Amyotrophic lateral sclerosis (ALS)	3	37	1.2	0.45	0.0241	9606.ENSP00000318822,9606.ENSP00000351908,9606.ENSP00000433138	BID,MAP3K5,CASP1
WP4329	miRNA role in immune response in sepsis	3	37	1.2	0.45	0.0241	9606.ENSP00000216341,9606.ENSP00000385675,9606.ENSP00000483825	GZMB,IL6,IKBKG
WP4562	Canonical NF-kB pathway	2	8	1.69	0.48	0.0241	9606.ENSP00000275015,9606.ENSP00000483825	NFKBIE,IKBKG
WP4396	Nonalcoholic fatty liver disease	5	154	0.81	0.4	0.0263	9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000351908,9606.ENSP00000385675,9606.ENSP00000394560	BID,CASP8,MAP3K5,IL6,MAPK9
WP3937	Microglia pathogen phagocytosis pathway	3	40	1.17	0.44	0.0267	9606.ENSP00000356505,9606.ENSP00000380948,9606.ENSP00000496959	NCF2,ITGB2,ITGAM
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	2	9	1.64	0.46	0.0267	9606.ENSP00000385675,9606.ENSP00000483825	IL6,IKBKG
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	3	41	1.16	0.44	0.0271	9606.ENSP00000351273,9606.ENSP00000433138,9606.ENSP00000483825	CASP8,CASP1,IKBKG
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	3	42	1.15	0.43	0.0283	9606.ENSP00000351273,9606.ENSP00000385675,9606.ENSP00000394560	CASP8,IL6,MAPK9
WP4658	Small cell lung cancer	4	95	0.92	0.41	0.0290	9606.ENSP00000318822,9606.ENSP00000351273,9606.ENSP00000386896,9606.ENSP00000483825	BID,CASP8,ITGA6,IKBKG
WP1971	Integrated cancer pathway	3	44	1.13	0.42	0.0305	9606.ENSP00000351273,9606.ENSP00000351908,9606.ENSP00000382805	CASP8,MAP3K5,BACH1
WP3929	Chemokine signaling pathway	5	165	0.78	0.39	0.0305	9606.ENSP00000267257,9606.ENSP00000296026,9606.ENSP00000363117,9606.ENSP00000367832,9606.ENSP00000483825	PXN,CXCL3,FGR,CCL7,IKBKG
WP75	Toll-like receptor signaling pathway	4	102	0.89	0.39	0.0348	9606.ENSP00000351273,9606.ENSP00000385675,9606.ENSP00000394560,9606.ENSP00000483825	CASP8,IL6,MAPK9,IKBKG
WP2513	Nanoparticle triggered regulated necrosis	2	12	1.52	0.42	0.0367	9606.ENSP00000351273,9606.ENSP00000355759	CASP8,PARP1
WP3611	Photodynamic therapy-induced AP-1 survival signaling	3	50	1.07	0.39	0.0397	9606.ENSP00000318822,9606.ENSP00000351908,9606.ENSP00000385675	BID,MAP3K5,IL6
